Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
INO > SEC Filings for INO > Form 8-K on 4-Mar-2014All Recent SEC Filings

Show all filings for INOVIO PHARMACEUTICALS, INC.

Form 8-K for INOVIO PHARMACEUTICALS, INC.


4-Mar-2014

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

On March 4, 2014, Inovio Pharmaceuticals, Inc. (the "Company") announced that it closed its underwritten public offering with respect to 21,810,900 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), including 2,844,900 shares of common stock issued pursuant to the underwriter's exercise of its overallotment option, at the public offering price of $2.90 per share.

The gross proceeds of the offering were approximately $63.3 million. Net proceeds to the Company, after deducting the underwriter's discounts and commission and other estimated offering expenses payable by the company, were approximately $59.2 million.

Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated acted as joint bookrunning managers for the offering. Brean Capital and Maxim Group LLC acted as co-managers of the offering.

The Company intends to use the net proceeds received from the sale of the common stock for general corporate purposes, including clinical trial expenses, research and development expenses, general and administrative expenses, manufacturing expenses and potential acquisitions of companies and technologies that complement its business.

The Securities were issued pursuant to a registration statement on Form S-3 that the Company filed with the Securities and Exchange Commission, which became effective on February 13, 2014 (File No. 333-193698).

On March 4, 2014, the Company issued a press release with respect to the closing of the offering described above. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated by reference herein.



Item 9.01. Financial Statements and Exhibits.

Exhibit
No. Exhibit Description

99.1 Inovio Pharmaceuticals, Inc. Press Release dated March 4, 2014


  Add INO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for INO - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.